{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:43:40Z","timestamp":1789497820514,"version":"build-2803163510"},"reference-count":138,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["cgfr.co.uk","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine & Growth Factor Reviews"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.cytogfr.2015.03.002","type":"journal-article","created":{"date-parts":[[2015,4,9]],"date-time":"2015-04-09T22:58:55Z","timestamp":1428620335000},"page":"451-461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Macrophage migration inhibitory factor: A key cytokine and therapeutic target in colon cancer"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2997-4194","authenticated-orcid":false,"given":"A.N.","family":"Gordon-Weeks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.Y.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.E.","family":"Yuzhalin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Muschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"April (6)","key":"10.1016\/j.cytogfr.2015.03.002_bib0695","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012","volume":"49","author":"Ferlay","year":"2013","journal-title":"Eur J Cancer"},{"issue":"February (2)","key":"10.1016\/j.cytogfr.2015.03.002_bib0700","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1136\/gut.29.2.206","article-title":"Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres","volume":"29","author":"Gyde","year":"1988","journal-title":"Gut"},{"issue":"November (18)","key":"10.1016\/j.cytogfr.2015.03.002_bib0705","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJM199011013231802","article-title":"Ulcerative colitis and colorectal cancer. A population-based study","volume":"323","author":"Ekbom","year":"1990","journal-title":"N Engl J Med"},{"issue":"November (11)","key":"10.1016\/j.cytogfr.2015.03.002_bib0710","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1136\/gut.35.11.1590","article-title":"Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis","volume":"35","author":"Gillen","year":"1994","journal-title":"Gut"},{"issue":"July (1)","key":"10.1016\/j.cytogfr.2015.03.002_bib0715","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/gut.39.1.87","article-title":"Promotion of colorectal neoplasia in experimental murine ulcerative colitis","volume":"39","author":"Okayasu","year":"1996","journal-title":"Gut"},{"issue":"April (8)","key":"10.1016\/j.cytogfr.2015.03.002_bib0720","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1158\/1078-0432.CCR-06-2727","article-title":"Ursodeoxycholic acid versus sulfasalazine in colitis-related colon carcinogenesis in mice","volume":"13","author":"Kohno","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"October (10)","key":"10.1016\/j.cytogfr.2015.03.002_bib0725","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/ibd.20489","article-title":"5-Aminosalicylic acid inhibits colitis-associated colorectal dysplasias in the mouse model of azoxymethane\/dextran sulfate sodium-induced colitis","volume":"14","author":"Clapper","year":"2008","journal-title":"Inflamm Bowel Dis"},{"issue":"May (9573)","key":"10.1016\/j.cytogfr.2015.03.002_bib0730","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(07)60747-8","article-title":"British Doctors Aspirin Trial and the UK-TIA Aspirin Trial. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies","volume":"369","author":"Flossmann","year":"2007","journal-title":"Lancet"},{"issue":"May (5)","key":"10.1016\/j.cytogfr.2015.03.002_bib0735","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S1470-2045(12)70112-2","article-title":"Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials","volume":"13","author":"Algra","year":"2012","journal-title":"Lancet Oncol"},{"issue":"July (7)","key":"10.1016\/j.cytogfr.2015.03.002_bib0740","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrc1388","article-title":"Cancer and the chemokine network","volume":"4","author":"Balkwill","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"November (11)","key":"10.1016\/j.cytogfr.2015.03.002_bib0745","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/qjmed\/hcq148","article-title":"Inflammation and cancer: macrophage migration inhibitory factor (MIF) \u2013 the potential missing link","volume":"103","author":"Conroy","year":"2010","journal-title":"Q J Med"},{"issue":"March (3)","key":"10.1016\/j.cytogfr.2015.03.002_bib0750","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.immuni.2007.03.005","article-title":"Macrophage migration inhibitory factor: a probable link between inflammation and cancer","volume":"26","author":"Bucala","year":"2007","journal-title":"Immunity"},{"issue":"July (3731)","key":"10.1016\/j.cytogfr.2015.03.002_bib0755","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1126\/science.153.3731.80","article-title":"Mechanism of a reaction in vitro associated with delayed-type hypersensitivity","volume":"153","author":"Bloom","year":"1966","journal-title":"Science"},{"issue":"July (1)","key":"10.1016\/j.cytogfr.2015.03.002_bib0760","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1073\/pnas.56.1.72","article-title":"Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction","volume":"56","author":"David","year":"1966","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"October (19)","key":"10.1016\/j.cytogfr.2015.03.002_bib0765","doi-asserted-by":"crossref","first-page":"7522","DOI":"10.1073\/pnas.86.19.7522","article-title":"Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor","volume":"86","author":"Weiser","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"October (10)","key":"10.1016\/j.cytogfr.2015.03.002_bib0770","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nri1200","article-title":"Macrophage migration inhibitory factor: a regulator of innate immunity","volume":"3","author":"Calandra","year":"2003","journal-title":"Nat Rev Immunol"},{"issue":"November (47)","key":"10.1016\/j.cytogfr.2015.03.002_bib0775","doi-asserted-by":"crossref","first-page":"14144","DOI":"10.1021\/bi00251a025","article-title":"Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF)","volume":"33","author":"Bernhagen","year":"1994","journal-title":"Biochemistry"},{"issue":"November (5)","key":"10.1016\/j.cytogfr.2015.03.002_bib0780","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1007\/s00436-012-3051-2","article-title":"Molecular and functional characterization of macrophage migration inhibitory factor (MIF) homolog of human from lymphatic filarial parasite Wuchereria bancrofti","volume":"111","author":"Sharma","year":"2012","journal-title":"Parasitol Res"},{"issue":"December (12)","key":"10.1016\/j.cytogfr.2015.03.002_bib0785","doi-asserted-by":"crossref","first-page":"5955","DOI":"10.1128\/IAI.66.12.5955-5963.1998","article-title":"Filarial nematode parasites secrete a homologue of the human cytokine macrophage migration inhibitory factor","volume":"66","author":"Pastrana","year":"1998","journal-title":"Infect Immun"},{"issue":"October (6448)","key":"10.1016\/j.cytogfr.2015.03.002_bib0790","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/365756a0","article-title":"MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia","volume":"365","author":"Bernhagen","year":"1993","journal-title":"Nature"},{"issue":"March (11)","key":"10.1016\/j.cytogfr.2015.03.002_bib0795","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1021\/bi982184o","article-title":"Crystal structure of human D-dopachrome tautomerase, a homologue of macrophage migration inhibitory factor, at 1.54 A resolution","volume":"38","author":"Sugimoto","year":"1999","journal-title":"Biochemistry"},{"issue":"November (6)","key":"10.1016\/j.cytogfr.2015.03.002_bib0800","first-page":"415","article-title":"Crystal structure of macrophage migration inhibitory factor (MIF), a glucocorticoid-induced regulator of cytokine production, reveals a unique architecture","volume":"108","author":"Lolis","year":"1996","journal-title":"Proc Assoc Am Physicians"},{"issue":"March (3)","key":"10.1016\/j.cytogfr.2015.03.002_bib0805","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nsb0396-259","article-title":"Crystal structure of the macrophage migration inhibitory factor from rat liver","volume":"3","author":"Suzuki","year":"1996","journal-title":"Nat Struct Biol"},{"issue":"May (11)","key":"10.1016\/j.cytogfr.2015.03.002_bib0810","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1073\/pnas.93.11.5191","article-title":"Crystal structure at 2.6-A resolution of human macrophage migration inhibitory factor","volume":"93","author":"Sun","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"June (22)","key":"10.1016\/j.cytogfr.2015.03.002_bib0815","doi-asserted-by":"crossref","first-page":"7346","DOI":"10.1021\/bi990306m","article-title":"Pro-1 of macrophage migration inhibitory factor functions as a catalytic base in the phenylpyruvate tautomerase activity","volume":"38","author":"Lubetsky","year":"1999","journal-title":"Biochemistry"},{"issue":"August (32)","key":"10.1016\/j.cytogfr.2015.03.002_bib0820","doi-asserted-by":"crossref","first-page":"9671","DOI":"10.1021\/bi000373c","article-title":"Mechanism of the phenylpyruvate tautomerase activity of macrophage migration inhibitory factor: properties of the P1G, P1A, Y95F, and N97A mutants","volume":"39","author":"Stamps","year":"2000","journal-title":"Biochemistry"},{"issue":"September (9)","key":"10.1016\/j.cytogfr.2015.03.002_bib0825","doi-asserted-by":"crossref","first-page":"e45024","DOI":"10.1371\/journal.pone.0045024","article-title":"Characterization of molecular determinants of the conformational stability of macrophage migration inhibitory factor: leucine 46 hydrophobic pocket","volume":"7","author":"El-Turk","year":"2012","journal-title":"PLoS ONE"},{"issue":"October (40)","key":"10.1016\/j.cytogfr.2015.03.002_bib0830","doi-asserted-by":"crossref","first-page":"10740","DOI":"10.1021\/bi800603x","article-title":"The conformational flexibility of the carboxy terminal residues 105\u2013114 is a key modulator of the catalytic activity and stability of macrophage migration inhibitory factor","volume":"47","author":"El-Turk","year":"2008","journal-title":"Biochemistry"},{"issue":"March (3)","key":"10.1016\/j.cytogfr.2015.03.002_bib0835","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1096\/fj.10-168559","article-title":"MIF-chemokine receptor interactions in atherogenesis are dependent on an N-loop-based 2-site binding mechanism","volume":"25","author":"Kraemer","year":"2011","journal-title":"FASEB J"},{"issue":"July (28)","key":"10.1016\/j.cytogfr.2015.03.002_bib0840","doi-asserted-by":"crossref","first-page":"24976","DOI":"10.1074\/jbc.M203220200","article-title":"The tautomerase active site of macrophage migration inhibitory factor is a potential target for discovery of novel anti-inflammatory agents","volume":"277","author":"Lubetsky","year":"2002","journal-title":"J Biol Chem"},{"issue":"October (42)","key":"10.1016\/j.cytogfr.2015.03.002_bib0845","doi-asserted-by":"crossref","first-page":"16278","DOI":"10.1073\/pnas.0804017105","article-title":"Structural determinants of MIF functions in CXCR2-mediated inflammatory and atherogenic leukocyte recruitment","volume":"105","author":"Weber","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"January (1)","key":"10.1016\/j.cytogfr.2015.03.002_bib0850","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF03402210","article-title":"The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction","volume":"2","author":"Rosengren","year":"1996","journal-title":"Mol Med"},{"issue":"July (1)","key":"10.1016\/j.cytogfr.2015.03.002_bib0855","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/jmbi.1998.1864","article-title":"Disulfide analysis reveals a role for macrophage migration inhibitory factor (MIF) as thiol-protein oxidoreductase","volume":"280","author":"Kleemann","year":"1998","journal-title":"J Mol Biol"},{"issue":"January (1)","key":"10.1016\/j.cytogfr.2015.03.002_bib0860","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1073\/pnas.011569399","article-title":"Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites","volume":"99","author":"Senter","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"November (7)","key":"10.1016\/j.cytogfr.2015.03.002_bib0865","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/BF03401892","article-title":"Localization of macrophage migration inhibitory factor (MIF) to secretory granules within the corticotrophic and thyrotrophic cells of the pituitary gland","volume":"1","author":"Nishino","year":"1995","journal-title":"Mol Med"},{"issue":"September (6544)","key":"10.1016\/j.cytogfr.2015.03.002_bib0870","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/377068a0","article-title":"MIF as a glucocorticoid-induced modulator of cytokine production","volume":"377","author":"Calandra","year":"1995","journal-title":"Nature"},{"issue":"February (2)","key":"10.1016\/j.cytogfr.2015.03.002_bib0875","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1046\/j.1365-2249.2001.01423.x","article-title":"Role of macrophage migration inhibitory factor (MIF) in murine antigen-induced arthritis: interaction with glucocorticoids","volume":"123","author":"Santos","year":"2001","journal-title":"Clin Exp Immunol"},{"issue":"July (15)","key":"10.1016\/j.cytogfr.2015.03.002_bib0880","doi-asserted-by":"crossref","first-page":"7849","DOI":"10.1073\/pnas.93.15.7849","article-title":"An essential regulatory role for macrophage migration inhibitory factor in T-cell activation","volume":"93","author":"Bacher","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"March","key":"10.1016\/j.cytogfr.2015.03.002_bib0885","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ijid.2013.12.006","article-title":"High levels of serum macrophage migration inhibitory factor and interleukin 10 are associated with a rapidly fatal outcome in patients with severe sepsis","volume":"20","author":"Chuang","year":"2014","journal-title":"Int J Infect Dis"},{"issue":"October (4)","key":"10.1016\/j.cytogfr.2015.03.002_bib0890","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/01.shk.0000140305.01641.c8","article-title":"Macrophage migration inhibitory factor levels correlate with fatal outcome in sepsis","volume":"22","author":"Bozza","year":"2004","journal-title":"Shock"},{"issue":"May (5)","key":"10.1016\/j.cytogfr.2015.03.002_bib0895","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/SHK.0b013e31802c024b","article-title":"Increases in serum macrophage migration inhibitory factor in patients with severe sepsis predict early mortality","volume":"27","author":"Chuang","year":"2007","journal-title":"Shock"},{"issue":"May (5)","key":"10.1016\/j.cytogfr.2015.03.002_bib0900","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nm1567","article-title":"MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment","volume":"13","author":"Bernhagen","year":"2007","journal-title":"Nat Med"},{"issue":"August (4)","key":"10.1016\/j.cytogfr.2015.03.002_bib0905","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/ijc.25991","article-title":"Tumor-derived macrophage migration inhibitory factor modulates the biology of head and neck cancer cells via neutrophil activation","volume":"129","author":"Dumitru","year":"2011","journal-title":"Int J Cancer"},{"issue":"December (11)","key":"10.1016\/j.cytogfr.2015.03.002_bib0910","doi-asserted-by":"crossref","first-page":"8072","DOI":"10.4049\/jimmunol.177.11.8072","article-title":"Macrophage migration inhibitory factor induces macrophage recruitment via CC chemokine ligand 2","volume":"177","author":"Gregory","year":"2006","journal-title":"J Immunol"},{"issue":"April (8)","key":"10.1016\/j.cytogfr.2015.03.002_bib0915","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.4049\/jimmunol.1003713","article-title":"Macrophage migration inhibitory factor and CD74 regulate macrophage chemotactic responses via MAPK and Rho GTPase","volume":"186","author":"Fan","year":"2011","journal-title":"J Immunol"},{"issue":"November (8)","key":"10.1016\/j.cytogfr.2015.03.002_bib0920","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3109\/10739680903210421","article-title":"Independent roles of macrophage migration inhibitory factor and endogenous, but not exogenous glucocorticoids in regulating leukocyte trafficking","volume":"16","author":"Gregory","year":"2009","journal-title":"Microcirculation"},{"issue":"September (9)","key":"10.1016\/j.cytogfr.2015.03.002_bib0925","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1002\/art.20470","article-title":"Reduced leukocyte-endothelial cell interactions in the inflamed microcirculation of macrophage migration inhibitory factor-deficient mice","volume":"50","author":"Gregory","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"December (12)","key":"10.1016\/j.cytogfr.2015.03.002_bib0930","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/01.RES.87.12.1202","article-title":"De novo expression of macrophage migration inhibitory factor in atherogenesis in rabbits","volume":"87","author":"Lin","year":"2000","journal-title":"Circ Res"},{"issue":"March (6)","key":"10.1016\/j.cytogfr.2015.03.002_bib0935","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1182\/blood-2005-05-2011","article-title":"Migration inhibitory factor up-regulates vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 via Src, PI3 kinase, and NFkappaB","volume":"107","author":"Amin","year":"2006","journal-title":"Blood"},{"issue":"July (2)","key":"10.1016\/j.cytogfr.2015.03.002_bib0940","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.4049\/jimmunol.0904104","article-title":"Macrophage migration inhibitory factor increases leukocyte\u2013endothelial interactions in human endothelial cells via promotion of expression of adhesion molecules","volume":"185","author":"Cheng","year":"2010","journal-title":"J Immunol"},{"issue":"August (16)","key":"10.1016\/j.cytogfr.2015.03.002_bib0945","doi-asserted-by":"crossref","first-page":"9354","DOI":"10.1073\/pnas.1533295100","article-title":"The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting","volume":"100","author":"Fingerle-Rowson","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"November (10)","key":"10.1016\/j.cytogfr.2015.03.002_bib0950","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1084\/jem.190.10.1375","article-title":"A proinflammatory cytokine inhibits P53 tumor suppressor activity","volume":"190","author":"Hudson","year":"1999","journal-title":"J Exp Med"},{"issue":"July (29)","key":"10.1016\/j.cytogfr.2015.03.002_bib0955","doi-asserted-by":"crossref","first-page":"20383","DOI":"10.1074\/jbc.M800050200","article-title":"Critical role of cysteine residue 81 of macrophage migration inhibitory factor (MIF) in MIF-induced inhibition of p53 activity","volume":"283","author":"Jung","year":"2008","journal-title":"J Biol Chem"},{"issue":"June (11)","key":"10.1016\/j.cytogfr.2015.03.002_bib0960","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1084\/jem.20030286","article-title":"MIF signal transduction initiated by binding to CD74","volume":"197","author":"Leng","year":"2003","journal-title":"J Exp Med"},{"issue":"October (4)","key":"10.1016\/j.cytogfr.2015.03.002_bib0965","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.immuni.2006.08.020","article-title":"CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex","volume":"25","author":"Shi","year":"2006","journal-title":"Immunity"},{"issue":"March (3)","key":"10.1016\/j.cytogfr.2015.03.002_bib0970","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1582-4934.2010.01041.x","article-title":"Hypoxia-induced endothelial secretion of macrophage migration inhibitory factor and role in endothelial progenitor cell recruitment","volume":"15","author":"Simons","year":"2011","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.cytogfr.2015.03.002_bib0975","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1471-2121-11-66","article-title":"Hypoxia stimulates the expression of macrophage migration inhibitory factor in human vascular smooth muscle cells via HIF-1alpha dependent pathway","volume":"11","author":"Fu","year":"2010","journal-title":"BMC Cell Biol"},{"issue":"September (4)","key":"10.1016\/j.cytogfr.2015.03.002_bib0980","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.bbrc.2006.06.148","article-title":"Dual regulation of macrophage migration inhibitory factor (MIF) expression in hypoxia by CREB and HIF-1","volume":"347","author":"Baugh","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"issue":"December (24)","key":"10.1016\/j.cytogfr.2015.03.002_bib0985","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1101\/gad.1471106","article-title":"HIF1alpha delays premature senescence through the activation of MIF","volume":"20","author":"Welford","year":"2006","journal-title":"Genes Dev"},{"issue":"December (12)","key":"10.1016\/j.cytogfr.2015.03.002_bib0990","first-page":"4721","article-title":"Identification of macrophage migration inhibitory factor as a potent endothelial cell growth-promoting agent released by ectopic human endometrial cells","volume":"85","author":"Yang","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"June (11)","key":"10.1016\/j.cytogfr.2015.03.002_bib0995","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1158\/0008-5472.CAN-11-3247","article-title":"MIF produced by bone marrow-derived macrophages contributes to teratoma progression after embryonic stem cell transplantation","volume":"72","author":"Wang","year":"2012","journal-title":"Cancer Res"},{"issue":"August (4)","key":"10.1016\/j.cytogfr.2015.03.002_bib1000","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1161\/01.RES.0000087641.56024.DA","article-title":"Migration inhibitory factor mediates angiogenesis via mitogen-activated protein kinase and phosphatidylinositol kinase","volume":"93","author":"Amin","year":"2003","journal-title":"Circ Res"},{"issue":"December (24)","key":"10.1016\/j.cytogfr.2015.03.002_bib1005","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1101\/gad.1506906","article-title":"HIF and MIF \u2013 a nifty way to delay senescence?","volume":"20","author":"Maity","year":"2006","journal-title":"Genes Dev"},{"issue":"December (12)","key":"10.1016\/j.cytogfr.2015.03.002_bib1010","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1093\/carcin\/bgt239","article-title":"Macrophage migratory inhibitory factor promotes bladder cancer progression via increasing proliferation and angiogenesis","volume":"34","author":"Choudhary","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.cytogfr.2015.03.002_bib1015","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/1471-2407-9-230","article-title":"Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer","volume":"9","author":"Verjans","year":"2009","journal-title":"BMC Cancer"},{"issue":"April (4)","key":"10.1016\/j.cytogfr.2015.03.002_bib1020","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1006\/cyto.1999.0562","article-title":"An antibody for macrophage migration inhibitory factor suppresses tumor growth and inhibits tumor-associated angiogenesis","volume":"12","author":"Ogawa","year":"2000","journal-title":"Cytokine"},{"issue":"October (4)","key":"10.1016\/j.cytogfr.2015.03.002_bib1025","first-page":"463","article-title":"Induction of cell arrest by transfection of macrophage migration inhibitory factor antisense plasmid","volume":"10","author":"Yasuda","year":"2002","journal-title":"Int J Mol Med"},{"issue":"November (5)","key":"10.1016\/j.cytogfr.2015.03.002_bib1030","first-page":"579","article-title":"Suppression of tumor growth through introduction of an antisense plasmid of macrophage migration inhibitory factor","volume":"10","author":"Sasaki","year":"2002","journal-title":"Int J Mol Med"},{"issue":"October (9)","key":"10.1016\/j.cytogfr.2015.03.002_bib1035","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/bjc.2012.392","article-title":"Macrophage migration inhibitory factor produced by the tumor stroma but not by tumor cells regulates angiogenesis in the B16-F10 melanoma model","volume":"107","author":"Girard","year":"2012","journal-title":"Br J Cancer"},{"issue":"June (12)","key":"10.1016\/j.cytogfr.2015.03.002_bib1040","doi-asserted-by":"crossref","first-page":"7549","DOI":"10.4049\/jimmunol.166.12.7549","article-title":"Non-small cell lung cancer cells induce monocytes to increase expression of angiogenic activity","volume":"166","author":"White","year":"2001","journal-title":"J Immunol"},{"issue":"July (7203)","key":"10.1016\/j.cytogfr.2015.03.002_bib1045","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"issue":"September (2)","key":"10.1016\/j.cytogfr.2015.03.002_bib1050","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.gene.2013.05.012","article-title":"Association of the macrophage migration inhibitory factor gene \u2013173G\/C polymorphism with inflammatory bowel disease: a meta-analysis of 4296 subjects","volume":"526","author":"Zhang","year":"2013","journal-title":"Gene"},{"issue":"3","key":"10.1016\/j.cytogfr.2015.03.002_bib1055","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00535-003-1284-7","article-title":"Association of the \u2013173 G\/C polymorphism of the macrophage migration inhibitory factor gene with ulcerative colitis","volume":"39","author":"Nohara","year":"2004","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.cytogfr.2015.03.002_bib1060","article-title":"Association between genetic polymorphism of the MIF gene and colorectal cancer in Taiwan","author":"Ramireddy","year":"2014","journal-title":"J Clin Lab Anal"},{"issue":"July (1)","key":"10.1016\/j.cytogfr.2015.03.002_bib1065","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1053\/gast.2002.34236","article-title":"Amelioration of dextran sulfate sodium-induced colitis by anti-macrophage migration inhibitory factor antibody in mice","volume":"123","author":"Ohkawara","year":"2002","journal-title":"Gastroenterology"},{"issue":"November (11)","key":"10.1016\/j.cytogfr.2015.03.002_bib1070","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ni720","article-title":"Development of chronic colitis is dependent on the cytokine MIF","volume":"2","author":"De Jong","year":"2001","journal-title":"Nat Immunol"},{"issue":"May (2)","key":"10.1016\/j.cytogfr.2015.03.002_bib1075","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2249.2005.02771.x","article-title":"Transgenic over-expression of macrophage migration inhibitory factor renders mice markedly more susceptible to experimental colitis","volume":"140","author":"Ohkawara","year":"2005","journal-title":"Clin Exp Immunol"},{"issue":"September (3)","key":"10.1016\/j.cytogfr.2015.03.002_bib1080","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1365-2249.2005.02877.x","article-title":"Macrophage migration inhibitory factor contributes to the development of acute dextran sulphate sodium-induced colitis in Toll-like receptor 4 knockout mice","volume":"141","author":"Ohkawara","year":"2005","journal-title":"Clin Exp Immunol"},{"issue":"March (3)","key":"10.1016\/j.cytogfr.2015.03.002_bib1085","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1053\/gast.2002.31891","article-title":"Ubiquitous production of macrophage migration inhibitory factor by human gastric and intestinal epithelium","volume":"122","author":"Maaser","year":"2002","journal-title":"Gastroenterology"},{"issue":"January (1)","key":"10.1016\/j.cytogfr.2015.03.002_bib1090","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10620-010-1240-3","article-title":"Induction and activation of adaptive immune populations during acute and chronic phases of a murine model of experimental colitis","volume":"56","author":"Hall","year":"2011","journal-title":"Dig Dis Sci"},{"issue":"October (1)","key":"10.1016\/j.cytogfr.2015.03.002_bib1095","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1749-6632.2012.06735.x","article-title":"Nutrition and physical activity in aging, obesity, and cancer","volume":"1271","author":"Nishihira","year":"2012","journal-title":"Ann NY Acad Sci"},{"issue":"August (2)","key":"10.1016\/j.cytogfr.2015.03.002_bib1100","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1164\/ajrccm.158.2.9707086","article-title":"Effect of anti-macrophage migration inhibitory factor antibody on lipopolysaccharide-induced pulmonary neutrophil accumulation","volume":"158","author":"Makita","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.cytogfr.2015.03.002_bib1105","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/art.30203","article-title":"Macrophage migration inhibitory factor regulates neutrophil chemotactic responses in inflammatory arthritis in mice","volume":"63","author":"Santos","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"April (7)","key":"10.1016\/j.cytogfr.2015.03.002_bib1110","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1158\/0008-5472.CAN-10-2583","article-title":"Tumor-associated neutrophils: new targets for cancer therapy","volume":"71","author":"Gregory","year":"2011","journal-title":"Cancer Res"},{"issue":"September (9)","key":"10.1016\/j.cytogfr.2015.03.002_bib1115","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1172\/JCI61067","article-title":"Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis","volume":"122","author":"Jamieson","year":"2012","journal-title":"J Clin Invest"},{"issue":"November (5)","key":"10.1016\/j.cytogfr.2015.03.002_bib1120","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ccr.2013.10.009","article-title":"CXCR2-expressing myeloid-derived suppressor cells are essential to promote colitis-associated tumorigenesis","volume":"24","author":"Katoh","year":"2013","journal-title":"Cancer Cell"},{"issue":"February (2)","key":"10.1016\/j.cytogfr.2015.03.002_bib1125","first-page":"183","article-title":"Mouse models for the study of colon","volume":"30","author":"Rosenberg","year":"2009","journal-title":"Carcinogenesis"},{"issue":"June (9)","key":"10.1016\/j.cytogfr.2015.03.002_bib1130","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.ejca.2009.02.005","article-title":"Differential CD74 (major histocompatibility complex Class II invariant chain) expression in mouse and human intestinal adenomas","volume":"45","author":"Cuthbert","year":"2009","journal-title":"Eur J Cancer"},{"issue":"October (10)","key":"10.1016\/j.cytogfr.2015.03.002_bib1135","first-page":"3298","article-title":"Expression of interleukin 8 and its receptors in human colon carcinoma cells with different metastatic potentials","volume":"7","author":"Li","year":"2001","journal-title":"Clin Cancer Res"},{"issue":"May (11)","key":"10.1016\/j.cytogfr.2015.03.002_bib1140","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/bjc.2012.177","article-title":"Interleukin-8 and its receptor CXCR2 in the tumor microenvironment promote colon cancer growth, progression and metastasis","volume":"106","author":"Lee","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cytogfr.2015.03.002_bib1145","doi-asserted-by":"crossref","DOI":"10.1158\/1535-7163.MCT-11-0915","article-title":"The CXCR2 antagonist, SCH-527123, demonstrates antitumor activity and sensitizes cells to oxaliplatin in preclinical colon cancer models","author":"Ning","year":"2012","journal-title":"Mol Cancer Ther"},{"issue":"April (15)","key":"10.1016\/j.cytogfr.2015.03.002_bib1150","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.3748\/wjg.14.2308","article-title":"Inhibition of CXCR4 activity with AMD3100 decreases invasion of human colorectal cancer cells in vitro","volume":"14","author":"Li","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"January (2)","key":"10.1016\/j.cytogfr.2015.03.002_bib1155","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ijc.27670","article-title":"The role of CXCR3 and CXCR4 in colorectal cancer metastasis","volume":"132","author":"Murakami","year":"2013","journal-title":"Int J Cancer"},{"issue":"June (11)","key":"10.1016\/j.cytogfr.2015.03.002_bib1160","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.1158\/0008-5472.CAN-09-3828","article-title":"Autocrine induction of invasive and metastatic phenotypes by the MIF-CXCR4 axis in drug-resistant human colon cancer cells","volume":"70","author":"Dessein","year":"2010","journal-title":"Cancer Res"},{"issue":"December (6)","key":"10.1016\/j.cytogfr.2015.03.002_bib1165","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3892\/ijmm.2012.1141","article-title":"Stromal cell-derived factor-1\u03b1 and macrophage migration-inhibitory factor induce metastatic behavior in CXCR4-expressing colon cancer cells","volume":"30","author":"Shin","year":"2012","journal-title":"Int J Mol Med"},{"issue":"July (13)","key":"10.1016\/j.cytogfr.2015.03.002_bib1170","first-page":"3833","article-title":"The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases","volume":"63","author":"Zeelenberg","year":"2003","journal-title":"Cancer Res"},{"issue":"September (9)","key":"10.1016\/j.cytogfr.2015.03.002_bib1175","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1245\/s10434-009-0599-x","article-title":"Hepatic stellate cells promote liver metastasis of colon cancer cells by the action of SDF-1\/CXCR4 axis","volume":"16","author":"Matsusue","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"April (12)","key":"10.1016\/j.cytogfr.2015.03.002_bib1180","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1200\/JCO.2005.07.078","article-title":"Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival","volume":"23","author":"Kim","year":"2005","journal-title":"J Clin Oncol"},{"issue":"March (5)","key":"10.1016\/j.cytogfr.2015.03.002_bib1185","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1158\/1078-0432.CCR-04-1195","article-title":"Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer","volume":"11","author":"Schimanski","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.cytogfr.2015.03.002_bib1190","first-page":"1","article-title":"Enhanced expression of CD74 in gastrointestinal cancers and benign tissues","volume":"4","author":"Gold","year":"2010","journal-title":"Int J Clin Exp Pathol"},{"issue":"October (2)","key":"10.1016\/j.cytogfr.2015.03.002_bib1195","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1046\/j.1365-2567.1999.00868.x","article-title":"Cell surface expression and metabolism of major histocompatibility complex class II invariant chain (CD74) by diverse cell lines","volume":"98","author":"Ong","year":"1999","journal-title":"Immunology"},{"issue":"July (26)","key":"10.1016\/j.cytogfr.2015.03.002_bib1200","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.3748\/wjg.v16.i26.3258","article-title":"CD74 is a survival receptor on colon epithelial cells","volume":"16","author":"Maharshak","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"June (6)","key":"10.1016\/j.cytogfr.2015.03.002_bib1205","doi-asserted-by":"crossref","first-page":"e98656","DOI":"10.1371\/journal.pone.0098656","article-title":"Chronic macrophage migration inhibitory factor exposure induces mesenchymal epithelial transition and promotes gastric and colon cancers","volume":"9","author":"Morris","year":"2014","journal-title":"PLOS ONE"},{"issue":"May (9)","key":"10.1016\/j.cytogfr.2015.03.002_bib1210","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1002\/ijc.25562","article-title":"Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models","volume":"128","author":"Ning","year":"2011","journal-title":"Int J Cancer"},{"issue":"November (11)","key":"10.1016\/j.cytogfr.2015.03.002_bib1215","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF03401765","article-title":"Involvement of macrophage migration inhibitory factor (MIF) in the mechanism of tumor cell growth","volume":"4","author":"Takahashi","year":"1998","journal-title":"Mol Med"},{"issue":"1\u20132","key":"10.1016\/j.cytogfr.2015.03.002_bib1220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2119\/molmed.2008.00107","article-title":"Macrophage migration inhibitory factor promotes colorectal cancer","volume":"15","author":"He","year":"2009","journal-title":"Mol Med"},{"issue":"February (3)","key":"10.1016\/j.cytogfr.2015.03.002_bib1225","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1158\/1078-0432.1050.11.3","article-title":"Macrophage migration inhibitory factor promotes tumor invasion and metastasis via the Rho-dependent pathway","volume":"11","author":"Sun","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"October (8)","key":"10.1016\/j.cytogfr.2015.03.002_bib1230","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.4049\/jimmunol.1102152","article-title":"Role of macrophage migration inhibitory factor in the regulatory T cell response of tumor-bearing mice","volume":"189","author":"Choi","year":"2012","journal-title":"J Immunol"},{"issue":"March (7\u20138)","key":"10.1016\/j.cytogfr.2015.03.002_bib1235","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.cca.2010.12.024","article-title":"Identification of biomarkers to improve diagnostic sensitivity of sporadic colorectal cancer in patients with low preoperative serum carcinoembryonic antigen by clinical proteomic analysis","volume":"412","author":"Chen","year":"2011","journal-title":"Clin Chim Acta"},{"issue":"May (5)","key":"10.1016\/j.cytogfr.2015.03.002_bib1240","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/01.MP.0000068235.45178.C1","article-title":"Prognostic values of galectin-3 and the macrophage migration inhibitory factor (MIF) in human colorectal cancers","volume":"16","author":"Legendre","year":"2003","journal-title":"Mod Pathol"},{"issue":"December (12)","key":"10.1016\/j.cytogfr.2015.03.002_bib1245","first-page":"1275","article-title":"Comparison of two lymphokines (macrophage migration inhibition, leukocyte adherence inhibition factors) and carcinoembryonic antigen, in colorectal cancer and colonic premalignant lesions","volume":"82","author":"Shkolnik","year":"1987","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cytogfr.2015.03.002_bib1250","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/1479-5876-11-253","article-title":"Detection of serological biomarkers by proximity extension assay for detection of colorectal neoplasias in symptomatic individuals","volume":"11","author":"Thorsen","year":"2013","journal-title":"J Transl Med"},{"issue":"May (5)","key":"10.1016\/j.cytogfr.2015.03.002_bib1255","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1309\/GFCLLRH8A68XKMJN","article-title":"Macrophage migration inhibitory factor may be used as an early diagnostic marker in colorectal carcinomas","volume":"129","author":"Lee","year":"2008","journal-title":"Am J Clin Pathol"},{"issue":"May (5)","key":"10.1016\/j.cytogfr.2015.03.002_bib1260","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/eji.201243162","article-title":"Partial MHC class II constructs inhibit MIF\/CD74 binding and downstream effects","volume":"43","author":"Benedek","year":"2013","journal-title":"Eur J Immunol"},{"issue":"June (12)","key":"10.1016\/j.cytogfr.2015.03.002_bib1265","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1021\/jm010534q","article-title":"Inhibition of MIF bioactivity by rational design of pharmacological inhibitors of MIF tautomerase activity","volume":"45","author":"Dios","year":"2002","journal-title":"J Med Chem"},{"issue":"January (1)","key":"10.1016\/j.cytogfr.2015.03.002_bib1270","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4155\/fmc.10.281","article-title":"MIF as a disease target: ISO-1 as a proof-of-concept therapeutic","volume":"3","author":"Al-Abed","year":"2011","journal-title":"Future Med Chem"},{"issue":"July (14)","key":"10.1016\/j.cytogfr.2015.03.002_bib1275","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1016\/j.bmc.2010.05.010","article-title":"An integrative in silico methodology for the identification of modulators of macrophage migration inhibitory factor (MIF) tautomerase activity","volume":"18","author":"El Turk","year":"2010","journal-title":"Bioorg Med Chem"},{"issue":"August (34)","key":"10.1016\/j.cytogfr.2015.03.002_bib1280","doi-asserted-by":"crossref","first-page":"26581","DOI":"10.1074\/jbc.M110.113951","article-title":"Identification and characterization of novel classes of macrophage migration inhibitory factor (MIF) inhibitors with distinct mechanisms of action","volume":"285","author":"Ouertatani-Sakouhi","year":"2010","journal-title":"J Biol Chem"},{"issue":"August (36)","key":"10.1016\/j.cytogfr.2015.03.002_bib1285","doi-asserted-by":"crossref","first-page":"30653","DOI":"10.1074\/jbc.M112.385583","article-title":"A novel allosteric inhibitor of macrophage migration inhibitory factor (MIF)","volume":"287","author":"Bai","year":"2012","journal-title":"J Biol Chem"},{"issue":"June (25)","key":"10.1016\/j.cytogfr.2015.03.002_bib1290","doi-asserted-by":"crossref","first-page":"11313","DOI":"10.1073\/pnas.1002716107","article-title":"Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast","volume":"107","author":"Cho","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"15","key":"10.1016\/j.cytogfr.2015.03.002_bib1295","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.2165\/00003495-200565150-00014","article-title":"Infliximab: a review of its use in Crohn's disease and rheumatoid arthritis","volume":"65","author":"Siddiqui","year":"2005","journal-title":"Drugs"},{"issue":"September (9)","key":"10.1016\/j.cytogfr.2015.03.002_bib1300","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.intimp.2011.04.017","article-title":"Characterization, epitope identification and mechanisms of the anti-septic capacity of monoclonal antibodies against macrophage migration inhibitory factor","volume":"11","author":"Zhang","year":"2011","journal-title":"Int Immunopharmacol"},{"issue":"March (10)","key":"10.1016\/j.cytogfr.2015.03.002_bib1305","doi-asserted-by":"crossref","first-page":"7446","DOI":"10.1074\/jbc.M111.329664","article-title":"Neutralization of macrophage migration inhibitory factor (MIF) by fully human antibodies correlates with their specificity for the \u03b2-sheet structure of MIF","volume":"287","author":"Kerschbaumer","year":"2012","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.cytogfr.2015.03.002_bib1310","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a001008","article-title":"TP53 mutations in human cancers: origins, consequences, and clinical use","volume":"2","author":"Olivier","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"October (4)","key":"10.1016\/j.cytogfr.2015.03.002_bib1315","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.3892\/ijo.2014.2551","article-title":"ISO-66, a novel inhibitor of macrophage migration, shows efficacy in melanoma and colon cancer models","volume":"45","author":"Ioannou","year":"2014","journal-title":"Int J Oncol"},{"issue":"April (1\u20133)","key":"10.1016\/j.cytogfr.2015.03.002_bib1320","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ejphar.2009.02.031","article-title":"A fluorinated analog of ISO-1 blocks the recognition and biological function of MIF and is orally efficacious in a murine model of colitis","volume":"607","author":"Dagia","year":"2009","journal-title":"Eur J Pharmacol"},{"issue":"March (3)","key":"10.1016\/j.cytogfr.2015.03.002_bib1325","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.gastro.2006.12.028","article-title":"Sex steroid regulation of macrophage migration inhibitory factor in normal and inflamed colon in the female rat","volume":"132","author":"Houdeau","year":"2007","journal-title":"Gastroenterology"},{"issue":"June (5)","key":"10.1016\/j.cytogfr.2015.03.002_bib1330","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cyto.2004.02.007","article-title":"Inhibition of joint inflammation and destruction induced by anti-type II collagen antibody\/lipopolysaccharide (LPS)-induced arthritis in mice due to deletion of macrophage migration inhibitory factor (MIF)","volume":"26","author":"Ichiyama","year":"2004","journal-title":"Cytokine"},{"issue":"May (5)","key":"10.1016\/j.cytogfr.2015.03.002_bib1335","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/art.20190","article-title":"Macrophage migration inhibitory factor up-regulates the expression of interleukin-8 messenger RNA in synovial fibroblasts of rheumatoid arthritis patients: common transcriptional regulatory mechanism between interleukin-8 and interleukin-1beta","volume":"50","author":"Onodera","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"November (44)","key":"10.1016\/j.cytogfr.2015.03.002_bib1340","doi-asserted-by":"crossref","first-page":"36541","DOI":"10.1074\/jbc.C500243200","article-title":"ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis","volume":"280","author":"Al-Abed","year":"2005","journal-title":"J Biol Chem"},{"issue":"November (11)","key":"10.1016\/j.cytogfr.2015.03.002_bib1345","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1096\/fj.10-162347","article-title":"A small-molecule inhibitor of macrophage migration inhibitory factor for the treatment of inflammatory disease","volume":"24","author":"Kithcart","year":"2010","journal-title":"FASEB J"},{"issue":"February (3)","key":"10.1016\/j.cytogfr.2015.03.002_bib1350","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.4049\/jimmunol.170.3.1274","article-title":"In vivo blockade of macrophage migration inhibitory factor ameliorates acute experimental autoimmune encephalomyelitis by impairing the homing of encephalitogenic T cells to the central nervous system","volume":"170","author":"Denkinger","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2015.03.002_bib1355","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1465-9921-14-27","article-title":"Small molecular modulation of macrophage migration inhibitory factor in the hyperoxia-induced mouse model of bronchopulmonary dysplasia","volume":"14","author":"Sun","year":"2013","journal-title":"Respir Res"},{"issue":"July (7)","key":"10.1016\/j.cytogfr.2015.03.002_bib1360","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1210\/en.2004-1393","article-title":"Critical role of macrophage migration inhibitory factor activity in experimental autoimmune diabetes","volume":"146","author":"Cvetkovic","year":"2005","journal-title":"Endocrinology"},{"issue":"January (1)","key":"10.1016\/j.cytogfr.2015.03.002_bib1365","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.atherosclerosis.2005.03.028","article-title":"Reduction of the aortic inflammatory response in spontaneous atherosclerosis by blockade of macrophage migration inhibitory factor (MIF)","volume":"184","author":"Burger-Kentischer","year":"2006","journal-title":"Atherosclerosis"},{"issue":"April (4)","key":"10.1016\/j.cytogfr.2015.03.002_bib1370","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1183\/09031936.06.00107004","article-title":"Role of macrophage migration inhibitory factor in ovalbumin-induced airway inflammation in rats","volume":"27","author":"Kobayashi","year":"2006","journal-title":"Eur Respir J"},{"issue":"January (1)","key":"10.1016\/j.cytogfr.2015.03.002_bib1375","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s00011-007-5184-9","article-title":"Blockade of macrophage migration inhibitory factor (MIF) prevents the antigen-induced response in a murine model of allergic airway inflammation","volume":"56","author":"Amano","year":"2007","journal-title":"Inflamm Res"},{"issue":"October (9\u201310)","key":"10.1016\/j.cytogfr.2015.03.002_bib1380","doi-asserted-by":"crossref","first-page":"400","DOI":"10.2119\/molmed.2009.00128","article-title":"ISO-1, a macrophage migration inhibitory factor antagonist, inhibits airway remodeling in a murine model of chronic asthma","volume":"16","author":"Chen","year":"2010","journal-title":"Mol Med"}],"container-title":["Cytokine & Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610115000283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610115000283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T05:55:37Z","timestamp":1691560537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610115000283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":138,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S1359610115000283"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2015.03.002","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Macrophage migration inhibitory factor: A key cytokine and therapeutic target in colon cancer","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2015.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}